advertisement
Vavvas DG 26
Showing records 1 to 25 | Display all abstracts from Vavvas DG104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Saini C
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Moos WH
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Chen TC
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Faller DV
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Young LH
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Glavas IP
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Vavvas DG
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Harpp DN
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Vangel M
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Kamperi N
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Papaliodis GN
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Kanara I; Kodukula K
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Mukai S; Turalba AV
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Mavrakis AN
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Rhee DJ
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Pernokas J; Pernokas M
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Wu DM
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Pinkert CA
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Eliott D; Miller JB
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Powers WR; Sampani K
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Song BJ
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Steliou K
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Shen LQ; Pasquale LR
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Tamvakopoulos C; Vavvas DG
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Chodosh J
American Journal of Ophthalmology 2022; 243: 42-54